Investment insights & portfolio guides
Original data, practical guides, and honest analysis for long-term investors.
Legal & General (LGEN) Analysis: How a Simpler Strategy Secures Its 7.6% Yield
Legal & General is aggressively simplifying its business while buying back stock. We look at how elevated global interest rates and a leaner structure are supporting its heavy cash payouts.
Mirbud S.A. (MRB.WA) Analysis: Paving Poland's High-Speed Future
Poland is pouring billions into national mega-projects, and general contractor Mirbud is right in the mix. But does strong revenue growth translate into durable shareholder returns?
Mo-BRUK’s Valuation Gap: How Poland’s Waste Management Leader Justifies a 52% Growth Spurt
Poland's shifting environmental laws are driving heavy demand for hazardous waste processing. We explore whether Mo-BRUK's aggressive capacity expansion justifies its current valuation.
Profits versus cash: The tension driving KRUK S.A. today
Investors in KRUK S.A. are currently staring at a fascinating contradiction. While the company's accounting profits have stalled, its actual cash generation is hitting record highs.
The hidden cost of scale: What the numbers say about Hims & Hers
Hims & Hers is adding subscribers at a record pace, but the financial data tells a deeper story. We look past the top-line growth to explore the true cost of scaling a global telehealth platform.
Untangling the spin-off: Creotech Quantum’s 1-billion PLN deep-tech gamble
Creotech Quantum entered the Warsaw Stock Exchange this year with a clear mission but a complicated financial slate. Here is a look at the actual business behind the deep-tech spin-off.
From Rebar to Ammunition: Is the Market Misjudging Cognor's Steel Pivot?
On paper, this Polish steelmaker looks bogged down by negative margins and a heavy debt load. But a massive push into defense-grade materials and new European tariffs could rewrite its story.
Warsaw Stock Exchange: Sizing up the monopoly as Poland chases Europe's heavyweights
The Warsaw Stock Exchange controls the digital plumbing of Poland's capital markets. With new technology rollouts and record trading volumes, its competitive moat looks deep—but highly sensitive to global market sentiment.
Synektik’s robotic moat: Why Central Europe’s medical tech giant is shedding weight to grow
Synektik has built a lucrative business distributing advanced surgical robots across Central Europe. By spinning off its R&D arm, the company is refocusing on its highly profitable core operations.
How to track dividend income across all your brokerage accounts
Calculating your true dividend yield is harder than just multiplying your shares by a payout percentage. To get an accurate picture of your income, you have to track the cash that actually hits your account after taxes, fees, and currency conversions.
Moving the iron: How ASBISc Enterprises turns thin margins into high returns
ASBISc Enterprises operates on razor-thin margins as an IT distributor, but a booming AI infrastructure market and clever capital management are driving record profits.
How much of your portfolio should be in one stock
Capping your exposure to a single stock is one of the most reliable ways to protect your wealth. Here is how to handle your biggest winners and employer equity.
Zeta Global: The 44% Growth Engine Navigating the AI Software Boom
Zeta Global is growing top-line revenue at a blistering pace and throwing off massive cash flow, yet GAAP profitability remains elusive. Here is how the numbers stack up.
The hidden cost of fund fees over 30 years
A 1% fee doesn't sound like much. But over decades of compounding, it can quietly swallow hundreds of thousands of dollars of your potential wealth.
Drive-Thrus and Growing Pains: Is the Market Misjudging Dutch Bros?
Despite posting a 32% jump in quarterly revenue, Dutch Bros saw its stock tumble as investors focused on upcoming margin pressures. We explore whether the market is missing the long-term story.
Google Finance Portfolio Alternatives (2026): Two Ways to Replace It
People have been searching for a Google Finance portfolio replacement since 2017. There are really only two paths — build it yourself in Google Sheets, or use a dedicated tracker. Here's how to pick.
Morningstar Portfolio Manager Alternatives (2026): Where to Go After X-Ray
Morningstar retired Portfolio Manager and X-Ray in 2025, and no single tool replaces everything they did. Here's an honest map: which alternative covers which slice, and how to migrate your data.
Spreadsheet vs Portfolio Tracker: When Excel Stops Being Enough
Ask investors what tracker they use and the most common answer is a spreadsheet. Often that's the right call. Here's an honest map of where sheets crack — and how to tell when you've outgrown yours.
Yahoo Finance Portfolio Alternatives (2026): When a Watchlist Isn't Enough
Yahoo Finance portfolios are fine until you ask a real question: what's my actual return across brokers, with deposits and dividends counted properly? Here are the trackers that answer it.
Gold vs stocks: which actually protects you from inflation?
Equities offer growing cash flows and pricing power, while gold offers physical scarcity. We look at the historical data to see which asset actually preserves your purchasing power.
Best Free Portfolio Trackers in 2026 (Genuinely Free, Not Just a Trial)
Most 'free' portfolio trackers are really free trials with a paywall around the useful parts. Here are the ones that are genuinely free in 2026 — and how to choose between them.
Rigetti Computing: Pricing the Quantum Future at $5 Billion
Rigetti carries a multi-billion dollar price tag despite generating roughly $10 million in annual sales. Here is why the market is paying a steep premium for this full-stack quantum hardware builder.
Beyond the Quarry: How Midwest Limited is Carving a New Future in Rare Earths and Quartz
Midwest Limited is using the steady cash from its legacy granite business to fund a quiet expansion into quartz and rare earth elements.
Compound interest explained — the numbers that surprise people
Compound interest is the money you earn on both your original investment and the interest it has already generated.